64 results
8-K
EX-99.1
ABVC
ABVC BioPharma Inc
14 Mar 24
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
9:04am
into global coverage, we eagerly await the results of patent applications in the European Union, China, Japan, and others.
On December 30, 2022
8-K
EX-4.1
ABVC
ABVC BioPharma Inc
8 Feb 24
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
9:30am
or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).
“Issue Date” means
8-K
EX-10.3
ABVC
ABVC BioPharma Inc
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank
8-K
EX-10.3
ABVC
ABVC BioPharma Inc
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).
“Issue Date” means
8-K
EX-10.1
vr1blb0
27 Jul 23
Entry into a Material Definitive Agreement
9:14am
8-K
EX-10.1
56y1vkbqzyyaq d55rc
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-1.1
ik2ih4j
5 Aug 21
ABVC BioPharma, Inc. Announces Pricing of $6.875 Million Firm Commitment Offering
3:23pm
8-K
EX-1.1
74jtzoow3
12 May 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
ke3ij7tzkubnevser
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
10-KT
0dprzryu1rxzcnghq
13 Apr 18
Annual report (with FYE transition)
12:00am